BMS201038: Clinical Trials

5 trials of BMS201038, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Withdrawn 1

Follow BMS201038: new trials by email Literature Review of BMS201038 trials Research Report on BMS201038

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)
Lomitapide - Homozygous Familial Hypercholesterolaemia (HoFH)
Phase 3CompletedAmryt Pharma462020-12-142025-08-27
Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy
Lomitapide - Homozygous Familial Hypercholesterolemia
Phase 3WithdrawnAegerion Pharmaceuticals, Inc.2016-05-012018-02-22
Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy
lomitapide - Familial Hypercholesterolemia - Homozygous
Phase 3CompletedAegerion Pharmaceuticals, Inc.92014-04-022018-10-10
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
lomitapide - Familial Hypercholesterolemia
Phase 3CompletedAegerion Pharmaceuticals, Inc.192009-10-292018-06-13
A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)
AEGR-733 - Homozygous Familial Hypercholesterolemia
Phase 3CompletedAegerion Pharmaceuticals, Inc.292007-12-012018-03-20

Conditions studied

Homozygous Familial Hypercholesterolemia (5)  ·  Hypercholesterolemia (1)  ·  Hyperlipoproteinemia Type II (1)

Sponsors

Aegerion Pharmaceuticals, Inc. (4)  ·  Amryt Pharma (1)

Countries

Italy (3)  ·  Canada (2)  ·  South Africa (2)  ·  United States (2)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  Tunisia (1)

Top investigators

Marina Cuchel, MD, PhD (2)  ·  Mark Sumeray, MD (2)  ·  Mariko Harada-Shiba, M.D., Ph.D. (1)

Results publications

PMID 36520008, PMID 25897792, PMID 26723464, PMID 39426393